Anixa Biosciences receives South Korean patent for breast cancer vaccine

Go back to Anixa Biosciences receives South Korean patent for breast cancer vaccine
(NASDAQ: ANIX) Delayed: 2.70 --0 (-0%)
Previous Close $2.70    52 Week High
Open $2.70    52 Week Low
Day High $2.70    P/E N/A 
Day Low $2.70    EPS
Volume 2,212